Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Metronidazole Dermal Products
NCT03271983Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metronidazole in rosacea (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Pharmacokinetic Parameters at 25 hours. Started Apr 2019; status: completed.
02
Drugs
metronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03271983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03271983.